Update on the management of prostate cancer with goserelin acetate: patient perspectives
Shandra WilsonDivision of Urology, University of Colorado, Aurora, CO, USAAbstract: The guidelines for the use of androgen deprivation therapy (ADT) have changed significantly over the last 5 years. This paper reviews the current recommendations and documents the reasons for these changes, in a revi...
Main Author: | Shandra Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-08-01
|
Series: | Cancer Management and Research |
Online Access: | http://www.dovepress.com/update-on-the-management-of-prostate-cancer-with-goserelin-acetate-pat-a3447 |
Similar Items
-
The Use of Goserelin acetate in combination with radiotherapy for prostate cancer
by: Mask Roach III & Alejandra Izaguirre
Published: (2020-02-01) -
Unsuspected skin metastasis of adenocarcinoma of the prostate in a patient on goserelin (Zoladex)
by: Timothy Uzoma Mbaeri, et al.
Published: (2018-01-01) -
Development of identification test methods for triptorelin acetate and goserelin acetate substances using NMR spectroscopy
by: S. V Moiseev, et al.
Published: (2019-03-01) -
Primary Mediastinal Choriocarcinoma in an Elderly Patient with Concurrent Goserelin-Treated Prostate Adenocarcinoma
by: Rasmus Røge, et al.
Published: (2019-01-01) -
Reinduction of Hormone Sensitivity to Goserelin following Chemotherapy with Vinorelbine in Castration-Resistant Prostate Cancer
by: Tal Grenader, et al.
Published: (2010-01-01)